AAAAAA

   
Results: 1-25 | 26-48

Table of contents of journal:

Results: 1-25/48

Authors: Alter, MJ Shapiro, CN
Citation: Mj. Alter et Cn. Shapiro, Epidemiology and prevention of chronic hepatitis B and C in North and South America, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 3-8

Authors: Xu, ZY Zhao, SJ Mahoney, RT Deng, XQ Lin, XM Xu, J Ding, D
Citation: Zy. Xu et al., Epidemiology and control of hepatitis B and C in eastern Asia, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 9-14

Authors: Attia, MA
Citation: Ma. Attia, Prevalence of hepatitis B and C in Egypt and Africa, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 15-24

Authors: Carrilho, FJ Correa, MCJM
Citation: Fj. Carrilho et Mcjm. Correa, Magnitude of hepatitis B and C in Latin America, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 25-34

Authors: Alvarado-Esquivel, C Wyseur, A Herrera-Ortiz, FD Ruiz-Maya, L Ruiz-Astorga, R Zarate-Aguilar, A Carrillo-Maravilla, E Herrera-Luna, R Morales-Macedo, MD Maertens, G Stuyver, L
Citation: C. Alvarado-esquivel et al., Hepatitis B and C virus infections in Mexico: genotypes and geographical distribution in blood donors and patients with liver disease, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 35-41

Authors: Alter, H
Citation: H. Alter, Natural history and clinical aspects of hepatitis C virus infection, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 43-50

Authors: Koziel, MJ
Citation: Mj. Koziel, The immunopathogenesis of hepatitis B virus infection, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 53-64

Authors: Nelson, DR Lau, JYN
Citation: Dr. Nelson et Jyn. Lau, Pathogenesis of chronic hepatitis C virus infection, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 65-76

Authors: Schaff, Z Lotz, G Eder, G Schulte-Hermann, R
Citation: Z. Schaff et al., Pathomorphology and apoptosis in viral hepatitis, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 77-86

Authors: Casey, JL
Citation: Jl. Casey, Hepatitis delta virus: molecular biology, pathogenesis and immunology, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 87-92

Authors: Kim, JP Fry, KE Wages, J
Citation: Jp. Kim et al., Molecular cloning and disease associations of hepatitis G virus, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 93-99

Authors: Pawlotsky, JM Gretch, DR
Citation: Jm. Pawlotsky et Dr. Gretch, Molecular tools for the treatment of hepatitis C, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 103-113

Authors: Rosenstraus, M Gutekunst, K Dale, B
Citation: M. Rosenstraus et al., Utility of hepatitis virus nucleic acid assays in therapeutic drug trials, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 115-127

Authors: Wilber, JC
Citation: Jc. Wilber, New developments in hepatitis C diagnostics and monitoring, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 129-132

Authors: Bukh, J Purcell, RH
Citation: J. Bukh et Rh. Purcell, Genomic structure and variability of hepatitis C virus, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 133-138

Authors: Van Geyt, C De Gendt, S Rombout, A Wyseur, A Maertens, G Rossau, R Stuyver, L
Citation: C. Van Geyt et al., A line probe assay for hepatitis B virus genotypes, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 139-145

Authors: Dagan, S Ilan, E Schinazi, RF
Citation: S. Dagan et al., Hepatitis C and hepatitis B animal models, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 149-159

Authors: Morrey, JD Korba, BE Sidwell, RW
Citation: Jd. Morrey et al., Transgenic mice as a chemotherapeutic model for hepatitis B virus infection, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 161-170

Authors: Tennant, BC Peek, SF Tochkov, IA Baldwin, BH Hornbuckle, WE Korba, BE Cote, PJ Gerin, JL
Citation: Bc. Tennant et al., The woodchuck in preclinical assessment of therapy for hepatitis B virus infection, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 171-176

Authors: Mason, WS Zhou, TL Nunes, F Condreay, LD Litwin, S Summers, J
Citation: Ws. Mason et al., Antiviral therapy for chronic hepadnavirus infections, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 177-184

Authors: Watts, AM Stanley, JR Shearer, MH Kennedy, RC
Citation: Am. Watts et al., Maternal and foetal vaccination strategies for hepatitis B surface antigenin non-human primate models: evaluation of therapeutic modalities during pregnancy, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 185-193

Authors: Gangemi, JD Korba, BE Tennant, BC Gerin, JL Cote, PJ Ueda, H Jay, G
Citation: Jd. Gangemi et al., Antiviral and anti-proliferative activities of a interferons in experimental hepatitis B virus infections, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 195-203

Authors: Blight, KJ Kolykhalov, AA Reed, KE Agapov, EV Rice, CM
Citation: Kj. Blight et al., Molecular virology of hepatitis C virus: an update with respect to potential antiviral targets, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 207-217

Authors: Littlejohn, M Locarnini, S Bartholomeusz, A
Citation: M. Littlejohn et al., Targets for inhibition of hepatitis C virus replication, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 219-227

Authors: Yao, NH Weber, PC
Citation: Nh. Yao et Pc. Weber, Helicase, a target for novel inhibitors of hepatitis C virus, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 229-233
Risultati: 1-25 | 26-48